Drug search by name

Cablivi and Bleeding

Result of checking the interaction of drug Cablivi and disease Bleeding for safety when used together.

Check result:

Cablivi <> Bleeding

Relevance: 23.07.2019 Reviewer: Shkutko P.M., M.D., in

When checking interaction based on authoritative sources Drugs.com, Rxlist.com, Webmd.com, Medscape.com there are contraindications or side effects that may cause harm or increase the negative effect from drug use in presence of concomitant diseases.

Consumer:

Caplacizumab increases the risk of bleeding. This risk is increased in patients with underlying coagulopathies (e.g., hemophilia, other coagulation factor deficiencies). It is also increased with concomitant use of drugs affecting hemostasis and coagulation. Treatment with caplacizumab should be interrupted if clinically significant bleeding occurs. Caution and close monitoring is advised.

Cablivi

Generic Name: caplacizumab

Brand Name: Cablivi

Synonyms: n.a.

What is Cablivi?